Nuklearmedizin 1984; 22(01): 04-08
DOI: 10.1055/s-0038-1624156
Originalarbeiten - Original Articles
Schattauer GmbH

Quality Control of Radiopharmaceuticals[*]

Artikel in mehreren Sprachen: English | deutsch
Gertrude Pfeiffer
1   From the Swiss Federal Institute for Reactor Research, Wiirenlingen, Switzerland
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 13. September 1983

Publikationsdatum:
10. Januar 2018 (online)

Summary

A good quality assurance system ensures that a product will be safe and suitable for the intended use. Quality control is an important part of the quality assurance system. Two main topics are discussed in this paper:

1. General aspects including regulations, possibilities, economics and responsibility; and

2. Procedures: Methods for the determination of the physical, chemical, pharmaceutical and biological purity with special regard to new methods, problems and pitfalls, e.g.

– the measurement of radioactivity using an isotope calibrator;

– the radionuclidic purity of 123I;

– alpha and beta-emitting impurities in 99mTc;

– High-performance liquid chromatography (HPLC);

– Mini-chromatograms; and

– the value of animal tests.

* 3rd International Symposium on Radiopharmacology, Freiburg i.Br., September 1983.


 
  • References

  • 1 Bayly R. J. Chemical and radiochemical purity. In: Quality Control in Nuclear Medicine.. Rhodes B. A. Ed.) 173 Mosby, St. Louis: 1977.
  • 2 Bläuenstein P. et al. Comparison of complexes with Tc-99m and Tc-99 using paper chromatography. In: Chromatography in Biochemistry, Medicine and Environmental Research.. Frigerio A. Ed.) 199 Elsevier, Amsterdam: 1983.
  • 3 Decombaz M. et al. Mesure de la pureté radionucléique du Tc-99m à usage médical. Institut de radiophysique appliquée de radioprotection et de mesure de la radioactivité, Lausanne, IRA-internal report
  • 4 Eckelmann W. C., Levenson S. M. Chromatographie purity of Tc-99m compounds. In: Quality Control in Nuclear Medicine.. Rhodes B. A. Ed.) 197 Mosby, St. Louis: 1977.
  • 5 Gardi A, Arpagaus G. R. Improved microtechnique for endotoxin assay by the Limulus Amebocyte Lysate Test. Analyt. Biochem. 109: 382 1980;
  • 6 Heide L. et al. Analytik radiochemischer Verunreinigungen in Radiopharmazeutika. Institut für Strahlenhygiene des Bundesgesundheitsamtes, STH-Berichte 15 (1979), 7 (1980), 9 (1980), 5 (1981)
  • 7 Hoppes D. D. Radionuclidic purity. In: Quality Control in Nuclear Medicine.. Rhodes B. A. Ed.) 164 Mosby, St. Louis: 1977.
  • 8 Johnston A. S. et al. Dose calibrator readings due to radionuclide impurities found in radiopharmaceuticals. Nucl. Med. 19: 1 1980;
  • 9 Kristensen Κ. Preparation and Control of Radiopharmaceuticals in Hospitals. Technical Reports Series No. 194. IAEA, Vienna.. 1979
  • 10 Phan T. h.e Tran, Wasnich R. Practical nuclear pharmacy. In: Practical Nuclear Medicine Series, Banyan Enterprises, Honolulu. 1979
  • 11 Pfeiffer G, Beranek I. Determination of the radiochemical purity of hippuran by HPLC. In: Progress in Radiopharmacology 3.. Cox P. H. Ed.) 27 Martinus Nijhoff, The Hague: 1982.
  • 12 Pfeiffer G. Analytical quality control. In: Safety and efficacy of radiopharmaceuticals.. Kristensen K. Ed.) 66 Martinus Nijhoff, The Hague: 1984.
  • 13 Williams C. C. et al. The accuracy of molybdeneum-99 assays in technetium99m solutions. Radiology. 445 1981;
  • 14 Zimmer A. M., Spiess S. M. The paper spot test: A rapid method for quantitating stannous concentrations in radiopharmaceutical kits. J. nucl. Med. 22: 465 1981;